Cary Queen

5.1k total citations · 2 hit papers
47 papers, 4.3k citations indexed

About

Cary Queen is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Cary Queen has authored 47 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 27 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Immunology. Recurrent topics in Cary Queen's work include Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (11 papers) and RNA and protein synthesis mechanisms (10 papers). Cary Queen is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (27 papers), Glycosylation and Glycoproteins Research (11 papers) and RNA and protein synthesis mechanisms (10 papers). Cary Queen collaborates with scholars based in United States, Malaysia and Mali. Cary Queen's co-authors include Laurence Jay Korn, David Baltimore, Jeannine Stafford, N M Avdalovic, Martin Rosenberg, Richard P. Junghans, Nicholas F. Landolfi, William P. Schneider, Man Sung Co and M S Co and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Cary Queen

47 papers receiving 3.9k citations

Hit Papers

Immunoglobulin gene transcription is activated by downstr... 1983 2026 1997 2011 1983 1984 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cary Queen United States 29 2.7k 1.2k 1.2k 699 482 47 4.3k
William D. Huse United States 17 2.3k 0.9× 690 0.6× 1.3k 1.0× 381 0.5× 347 0.7× 25 3.4k
Steven Kessler United States 23 2.6k 1.0× 1.9k 1.6× 974 0.8× 1.4k 1.9× 586 1.2× 50 5.7k
Clifford P. Stanners Canada 42 3.5k 1.3× 777 0.6× 1.7k 1.4× 801 1.1× 1.6k 3.2× 99 5.9k
M L Gefter United States 29 2.4k 0.9× 1.1k 0.9× 792 0.6× 761 1.1× 268 0.6× 44 3.8k
Hans H. Wandall Denmark 46 5.0k 1.9× 2.0k 1.6× 994 0.8× 350 0.5× 633 1.3× 125 6.7k
Donald Dowbenko United States 34 3.1k 1.2× 1.4k 1.1× 745 0.6× 401 0.6× 728 1.5× 50 5.5k
Peter L. Ey Australia 25 1.7k 0.6× 1.0k 0.9× 1.2k 1.0× 285 0.4× 210 0.4× 60 4.8k
Masazumi Matsumura United States 26 2.4k 0.9× 1.3k 1.1× 698 0.6× 282 0.4× 331 0.7× 35 4.1k
Óscar R. Burrone Italy 41 1.4k 0.5× 1.1k 0.9× 754 0.6× 839 1.2× 565 1.2× 150 4.9k
Ikuo Yamashina Japan 37 3.6k 1.4× 1.6k 1.3× 700 0.6× 555 0.8× 339 0.7× 179 5.4k

Countries citing papers authored by Cary Queen

Since Specialization
Citations

This map shows the geographic impact of Cary Queen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cary Queen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cary Queen more than expected).

Fields of papers citing papers by Cary Queen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cary Queen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cary Queen. The network helps show where Cary Queen may publish in the future.

Co-authorship network of co-authors of Cary Queen

This figure shows the co-authorship network connecting the top 25 collaborators of Cary Queen. A scholar is included among the top collaborators of Cary Queen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cary Queen. Cary Queen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Lihong, et al.. (2012). A Novel Monoclonal Antibody to Fibroblast Growth Factor 2 Effectively Inhibits Growth of Hepatocellular Carcinoma Xenografts. Molecular Cancer Therapeutics. 11(4). 864–872. 52 indexed citations
2.
Khoruzhii, O. V., Alexander Donchev, N. G. Galkin, et al.. (2008). Application of a polarizable force field to calculations of relative protein–ligand binding affinities. Proceedings of the National Academy of Sciences. 105(30). 10378–10383. 37 indexed citations
3.
Co, Man Sung, Nicholas F. Landolfi, Jon O. Nagy, et al.. (1999). Properties and pharmacokinetics of two humanized antibodies specific for L-selectin. Immunotechnology. 4(3-4). 253–266. 14 indexed citations
4.
Shan, Lin, Luke W. Guddat, Archana Thakur, et al.. (1999). Comparison of the three-dimensional structures of a humanized and a chimeric Fab of an anti-γ-interferon antibody. Journal of Molecular Recognition. 12(1). 19–32. 26 indexed citations
5.
He, Xingyue, Jennifer Melrose, Maximiliano Vásquez, et al.. (1998). Humanization and Pharmacokinetics of a Monoclonal Antibody with Specificity for Both E- and P-Selectin. The Journal of Immunology. 160(2). 1029–1035. 39 indexed citations
7.
Co, Man Sung, David A. Scheinberg, N M Avdalovic, et al.. (1993). Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody. Molecular Immunology. 30(15). 1361–1367. 55 indexed citations
8.
Caron, Philip, W Laird, M S Co, et al.. (1992). Engineered humanized dimeric forms of IgG are more effective antibodies.. The Journal of Experimental Medicine. 176(4). 1191–1195. 36 indexed citations
9.
Co, Man Sung & Cary Queen. (1991). Humanized antibodies for therapy. Nature. 351(6326). 501–502. 69 indexed citations
10.
Brown, Paul S., Gary L. Parenteau, Frederick M. Dirbas, et al.. (1991). Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.. Proceedings of the National Academy of Sciences. 88(7). 2663–2667. 83 indexed citations
11.
Junghans, Richard P., T. A. Waldmann, Nicholas F. Landolfi, et al.. (1990). Anti-Tac-H, a humanized antibody to the interleukin 2 receptor with new features for immunotherapy in malignant and immune disorders.. PubMed. 50(5). 1495–502. 125 indexed citations
12.
Bich‐Thuy, Lě Thi & Cary Queen. (1989). An enhancer associated with the mouse immunoglobin λf gene is specific for λ light chain producing cells. Nucleic Acids Research. 17(13). 5307–5322. 9 indexed citations
13.
Bich‐Thuy, Lě Thi & Cary Queen. (1988). Transfection of an immunoglobulin kappa gene into mature human B lymphocytes.. Molecular and Cellular Biology. 8(1). 511–513. 4 indexed citations
14.
Steege, Deborah A., Karen C. Cone, Cary Queen, & Martin Rosenberg. (1987). Bacteriophage lambda N gene leader RNA. RNA processing and translational initiation signals.. Journal of Biological Chemistry. 262(36). 17651–17658. 30 indexed citations
15.
Korn, Laurence Jay & Cary Queen. (1984). Analysis of Biological Sequences on Small Computers. DNA. 3(6). 421–436. 25 indexed citations
16.
Stafford, Jeannine & Cary Queen. (1983). Cell-type specific expression of a transfected immunoglobulin gene. Nature. 306(5938). 77–79. 102 indexed citations
17.
Queen, Cary & David Baltimore. (1983). Immunoglobulin gene transcription is activated by downstream sequence elements. Cell. 33(3). 741–748. 763 indexed citations breakdown →
18.
Queen, Cary, Susan T. Lord, Thomas F. McCutchan, & Maxine Singer. (1981). Three Segments from the Monkey Genome That Hybridize to Simian Virus 40 Have Common Structural Elements. Molecular and Cellular Biology. 1(12). 1061–1068. 5 indexed citations
19.
Queen, Cary & Martin Rosenberg. (1981). A promoter of pBR322 activated by cAMP receptor protein. Nucleic Acids Research. 9(14). 3365–3377. 86 indexed citations
20.
Queen, Cary & Laurence Jay Korn. (1980). [60] Computer analysis of nucleic acids and proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 65(1). 595–609. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026